Waters Corporation (WAT)

US — Healthcare Sector
Peers: IDXX  IQV  CRL  RVTY  MTD  DHR  TMO  TWST  ICLR  ILMN  SHC 

Automate Your Wheel Strategy on WAT

With Tiblio's Option Bot, you can configure your own wheel strategy including WAT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol WAT
  • Rev/Share 51.1813
  • Book/Share 36.2902
  • PB 8.2039
  • Debt/Equity 0.7123
  • CurrentRatio 1.7538
  • ROIC 0.1767

 

  • MktCap 17721515052.0
  • FreeCF/Share 10.4067
  • PFCF 28.6129
  • PE 26.7901
  • Debt/Assets 0.3261
  • DivYield 0
  • ROE 0.3502

 

  • Rating B
  • Score 3
  • Recommendation Neutral
  • P/E Score 1
  • DCF Score 4
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Upgrade WAT KeyBanc Capital Markets Sector Weight Overweight -- $460 March 31, 2025
Upgrade WAT Robert W. Baird Neutral Outperform $396 $407 March 26, 2025
Upgrade WAT Scotiabank Sector Perform Sector Outperform -- $450 Feb. 13, 2025
Upgrade WAT Barclays Underweight Equal Weight $360 $415 Feb. 10, 2025
Upgrade WAT Bernstein Market Perform Outperform -- $430 Jan. 10, 2025
Initiation WAT Scotiabank -- Sector Perform -- -- Dec. 23, 2024
Upgrade WAT Jefferies Hold Buy $355 $415 Oct. 8, 2024
Initiation WAT Wells Fargo -- Overweight -- $380 Aug. 28, 2024

News

Waters Corporation (WAT) Q4 2024 Earnings Call Transcript
WAT
Published: February 12, 2025 by: Seeking Alpha
Sentiment: Neutral

Waters Corporation (NYSE:WAT ) Q4 2024 Earnings Conference Call February 12, 2025 8:00 AM ET Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President & Chief Executive Officer Amol Chaubal - Senior Vice President & Chief Financial Officer Conference Call Participants Tycho Peterson - Jefferies Vijay Kumar - Evercore ISI Puneet Souda - Leerink Eve Burstein - Bernstein Brandon Couillard - Wells Fargo Dan Arias - Stifel Dan Brennan - TD Cowen Catherine Schulte - Baird Operator Good morning. Welcome to the Waters Corporation Fourth Quarter 2024 Financial Results Conference Call.

Read More
image for news Waters Corporation (WAT) Q4 2024 Earnings Call Transcript
Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2024 Financial Results
WAT
Published: February 12, 2025 by: PRNewsWire
Sentiment: Neutral

Highlights Fourth Quarter 2024 Sales of $873 million exceeded high-end of guidance range, grew 6% as reported and 8% in constant currency Instruments grew 8% and recurring revenue grew 9% in constant currency, as growth accelerated across all three reported regions Pharma grew 10% in constant currency, reflecting stronger-than-expected year-end spending dynamics and broad-based growth across the Americas, Europe, and Asia GAAP EPS of $3.88; non-GAAP EPS of $4.10 grew 13% as strong operational performance and better-than-expected sales volume offset foreign exchange headwinds Full-Year 2024 Sales exceeded guidance at $2,958 million, flat as reported and in organic constant currency GAAP …

Read More
image for news Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2024 Financial Results

About Waters Corporation (WAT)

  • IPO Date 1995-11-17
  • Website https://www.waters.com
  • Industry Medical - Diagnostics & Research
  • CEO Udit Batra
  • Employees 7600

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.